Zhuhai Rundu Pharmaceutical Co., Ltd. (SHE:002923)

Market Cap	5.26B +63.4%
Revenue (ttm)	1.19B -2.8%
Net Income	-51.99M
EPS	-0.16
Shares Out	334.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.15 (0.98%)
Ex-Dividend Date	May 30, 2025

Volume	8,035,320
Average Volume	10,016,545
Open	14.20
Previous Close	15.70
Day's Range	14.20 - 15.89
52-Week Range	9.50 - 19.56
Beta	0.21
RSI	77.45
Earnings Date	Apr 29, 2026

About SHE:002923

Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular; and pellets for excipient, antiulcerative, diabetes drug, anti-inflammatory, and anti-anginals. The company is also involved in the process development, quality research, and registration of chemical drugs. In addition, it provides branding services of drug products, as well as academic services. The comp...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 1,985
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002923

Financial Performance

In 2024, SHE:002923's revenue was 1.18 billion, a decrease of -8.48% compared to the previous year's 1.29 billion. Earnings were 39.88 million, a decrease of -40.38%.